Charles River Laboratories International (CRL) Net Income towards Common Stockholders Growth (1y) (2010 - 2025)
Charles River Laboratories International (CRL) Net Income towards Common Stockholders Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 12.89% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | -28.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | -28.21% |
| Sep 27, 2025 | -20.76% |
| Jun 28, 2025 | -41.85% |
| Mar 29, 2025 | -62.17% |
| Dec 28, 2024 | -215.30% |
| Sep 28, 2024 | -21.41% |
| Jun 29, 2024 | -7.25% |
| Mar 30, 2024 | -34.72% |
| Dec 30, 2023 | -1.07% |
| Sep 30, 2023 | -10.47% |
| Jul 1, 2023 | -12.33% |
| Apr 1, 2023 | 8.30% |
| Dec 31, 2022 | 35.24% |
| Sep 24, 2022 | -7.18% |
| Jun 25, 2022 | 23.07% |
| Mar 26, 2022 | 48.94% |
| Dec 25, 2021 | -3.03% |
| Sep 25, 2021 | 2.48% |
| Jun 26, 2021 | 32.88% |
| Mar 27, 2021 | 25.76% |